Resveratrol Mitigates Noise-Induced Cochlear Damage and Delays Hearing Loss in Wistar Rats

Area of Science:

• Ototoxicology
• Pharmacology
• Neuroscience

Background:

• Noise-induced hearing loss (NIHL) is a significant health concern.
• Evaluating otoprotective agents is crucial for preventing hearing damage.
• Resveratrol is investigated for its potential therapeutic properties.

Purpose of the Study:

• To assess the otoprotective effects of resveratrol on noise-induced hearing loss (NIHL).
• To evaluate resveratrol's impact on auditory function and cochlear morphology in a rat model.

Main Methods:

• A randomized controlled study using Wistar rats exposed to 100 dB SPL white noise for 10 days.
• Groups included control, noise-exposed, and noise-exposed plus resveratrol (10 mg/kg/day).
• Auditory function assessed via distortion product otoacoustic emissions (DPOAE) and auditory brainstem response (ABR); cochlear tissues examined histologically.

Main Results:

• Significant differences observed in DPOAE, ABR thresholds, and cochlear morphology between groups.
• Resveratrol administration modulated auditory responses and preserved cochlear structures compared to noise-exposed controls.

Conclusions:

• Resveratrol demonstrates a partial otoprotective effect against NIHL in rats.
• The findings suggest resveratrol may delay the onset of hearing loss.
• Further molecular research is recommended to elucidate resveratrol's therapeutic mechanisms in auditory pathways.